Viewing Study NCT05766592



Ignite Creation Date: 2024-05-06 @ 6:43 PM
Last Modification Date: 2024-10-26 @ 2:53 PM
Study NCT ID: NCT05766592
Status: RECRUITING
Last Update Posted: 2024-06-17
First Post: 2023-03-01

Brief Title: Affirmative Family and Individual Psychotherapy for Sexual and Gender Minority Adults and Their Nonaccepting Parents
Sponsor: Yale University
Organization: Yale University

Study Overview

Official Title: Affirmative Family and Individual Psychotherapy for Sexual and Gender Minority Adults and Their Nonaccepting Parents
Status: RECRUITING
Status Verified Date: 2024-09
Last Known Status: None
Delayed Posting: No
If Stopped, Why?: Not Stopped
Has Expanded Access: False
If Expanded Access, NCT#: N/A
Has Expanded Access, NCT# Status: N/A
Acronym: None
Brief Summary: The purpose of this study is to assess the efficacy of an LGBTQ-affirmative individual cognitive behavioral psychotherapy CBT and LGBTQ-affirmative family therapy attachment-based family therapy for sexual and gender minority young adults ABFT-SGM delivered via telehealth to a sample of sexual and gender minority adults with nonaccepting parents in New York Pennsylvania Connecticut and Israel The investigators will assess whether both treatments are associated with significant decreases in depressive and anxiety symptoms The investigators will also assess whether and how each treatment achieves reductions in mental health symptoms through specific mechanisms eg rejection sensitivity internalized stigma emotion dysregulation parental rejection and acceptance
Detailed Description: The purpose of this study is to assess the efficacy and purported change mechanisms in an LGBTQ-affirmative individual cognitive behavioral psychotherapy CBT and LGBTQ-affirmative family therapy attachment-based family therapy for sexual and gender minority young adults ABFT-SGM delivered via telehealth to a sample of sexual and gender minority adults in New York Pennsylvania Connecticut and Israel In this 2-arm randomized clinical trial RCT participants will receive 16 weekly sessions of either LGBTQ-affirmative CBT or ABFT-SGM Investigators will assess whether both treatments are associated with significant decreases in depressive and anxiety symptoms Investigators will also assess whether psychosocial mechanisms eg rejection sensitivity internalized stigma emotion dysregulation parental rejection and acceptance mediate reductions in psychological symptoms and whether such mediators differ between the two treatments Finally investigators will assess whether participants who begin treatment with higher levels of parental rejection benefit more from ABFT-SGM than from LGBTQ-affirmative CBT and whether participants with higher initial levels of maladaptive stress responses benefit more from LGBTQ-affirmative CBT

Study Oversight

Has Oversight DMC: None
Is a FDA Regulated Drug?: False
Is a FDA Regulated Device?: False
Is an Unapproved Device?: None
Is a PPSD?: None
Is a US Export?: None
Is an FDA AA801 Violation?: None